Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,508Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M1,508EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)21.9Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.510-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.8PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M15,350,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IXJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IXJKen Fisher 2016-03-31 Reduce-0.02%$90.5 - $102.62
($95.44)
$ 98.283%Reduce -86.86%12,122
IXJKen Fisher 2015-12-31 Add0.02%$99.78 - $105.97
($102.96)
$ 98.28-5%Add 380.03%92,228
IXJKen Fisher 2015-09-30 Add$96.45 - $113.73
($107.78)
$ 98.28-9%Add 187.71%19,213
IXJKen Fisher 2015-06-30 Add$107.16 - $112.88
($109.98)
$ 98.28-11%Add 9.14%6,678
IXJKen Fisher 2015-03-31 Reduce$98.86 - $110.66
($104.83)
$ 98.28-6%Reduce -13.27%6,119
IXJKen Fisher 2014-03-31 Buy $84.91 - $93
($89.14)
$ 98.2810%New holding5,950
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IXJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IXJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dubuc, PhilippeSenior Officer 2016-04-08Buy1,700$1.994838.69view
Dubuc, PhilippeSenior Officer 2016-04-08Buy3,300$24814view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-04-08Buy10,000$0.1565420view
Williams, Allan WilliamSenior Officer 2016-04-08Buy108,500$0.1189245.45view
Stefura, Naomi MarieSenior Officer 2016-04-08Sell4,200$14.6573.15view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell800$20.78372.95view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell400$20.77373.18view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell300$20.75373.64view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell100$20.72374.32view
Gentiletti, NelsonDirector or Senior Officer of Insider or Subsidiar 2016-04-08Sell900$20.7374.78view

Quarterly/Annual Reports about IXJ:

    News about IXJ:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Fed’s Dovish Stance – What Does it Mean May 03 2016
    How Did Eli Lilly’s Neuroscience Franchise Perform in 1Q16? May 02 2016
    The Fed Flies Like a Dove Apr 30 2016
    Advance Estimates of U.S. GDP Growth Apr 30 2016
    GlaxoSmithKline’s Stock Rose on Solid 1Q16 Earnings Apr 30 2016
    Johnson & Johnson’s 1Q16 Earnings: Consumer Segment Apr 26 2016
    The Fed and the Dangers of the ‘Dove’ Apr 21 2016
    2016 Investment Landscape: Right Sector at the Right Time Apr 19 2016
    Zimmer Biomet’s Competition in the Hip Implant Market Apr 13 2016
    Therapy Innovation Impacted Medtronic’s Consistent Revenue Apr 12 2016
    Pfizer’s 1Q16: A Valuation Cheat Sheet Apr 08 2016
    Sector ETFs to Capitalize on America's Aging Population (IBB, IXJ) Apr 08 2016
    How Structural Changes in the World Economy Affect Markets Apr 01 2016
    Exploring Pfizer’s Recent Corporate Developments Apr 01 2016
    Which Segments Will Contribute to Pfizer’s Growth in 1Q16? Apr 01 2016
    Low-Cost Exposure to U.S. Healthcare Firms Apr 01 2016
    How Will Novartis’s Sandoz Perform in 1Q16? Mar 29 2016
    Will Novartis’s 1Q16 Revenues Fall as Expected? Mar 24 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)